We show that a core set of co-regulated immune response genes display a pronounced and specific inverted expression profile from original discovery in an anti-inflammatory context (T1D patients treated with low-dose IL-2) compared to COVID-19 patients. This evidence concerns the gene IL2 and type 1 diabetes mellitus.